Stock Scorecard



Stock Summary for INVO Bioscience Inc (INVO) - $1.01 as of 3/26/2024 10:48:09 PM EST

Total Score

6 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for INVO

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for INVO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for INVO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for INVO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for INVO

Assisted Reproductive Technology (ART) Market 2023-2027 | US$ 8.23 billion growth is expected between 2022 to ... - PR Newswire 2/12/2024 2:24:00 AM
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy ( LHON ) 1/23/2024 1:00:00 PM
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors - Kymera Therapeutics ( NASDAQ:KYMR ) , Nanobiotix ( NASDAQ:NBTX ) 1/17/2024 1:00:00 PM
Assisted Reproductive Technology (ART) Market size to grow by USD 8.23 billion from 2022 to 2027, Europe to ... - PR Newswire 1/8/2024 7:15:00 AM
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Acutus Medical ( NASDAQ:AFIB ) , AgileThought ( NASDAQ:AGIL ) 11/21/2023 1:05:00 PM
Dow Jumps Over 500 Points; Home Depot Earnings Top Views - BioCardia ( NASDAQ:BCDA ) , Applied UV ( NASDAQ:AUVI ) 11/14/2023 8:10:00 PM
Crude Oil Moves Higher; Beauty Health Shares Plunge - BioCardia ( NASDAQ:BCDA ) , Applied UV ( NASDAQ:AUVI ) 11/14/2023 6:11:00 PM
Nasdaq Surges 2%; US Inflation Rate Slows In October - BioCardia ( NASDAQ:BCDA ) , Applied UV ( NASDAQ:AUVI ) 11/14/2023 2:50:00 PM
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket 11/14/2023 1:41:00 PM
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket - Absci ( NASDAQ:ABSI ) , Advent Technologies Hldgs ( NASDAQ:ADN ) 11/14/2023 12:41:00 PM

Financial Details for INVO

Company Overview

Ticker INVO
Company Name INVO Bioscience Inc
Country USA
Description INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions globally. The company is headquartered in Sarasota, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2023
Next Earnings Date 3/28/2024

Stock Price History

Last Day Price 1.01
Last Day Price Updated 3/26/2024 10:48:09 PM EST
Last Day Volume 16,615
Average Daily Volume 21,160
52-Week High 13.52
52-Week Low 0.50
Last Price to 52 Week Low 102.00%

Valuation Measures

Trailing PE N/A
Industry PE 50.34
Sector PE 60.76
5-Year Average PE -74.61
Free Cash Flow Ratio 2.40
Industry Free Cash Flow Ratio 67.97
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 0.37
Total Cash Per Share 0.42
Book Value Per Share Most Recent Quarter 0.15
Price to Book Ratio 7.62
Industry Price to Book Ratio 5.28
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 1.43
Industry Price to Sales Ratio Twelve Trailing Months 13.37
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 2,492,500
Market Capitalization 2,517,425
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -63.68%
Reported EPS 12 Trailing Months -10.34
Reported EPS Past Year -3.99
Reported EPS Prior Year -0.89
Net Income Twelve Trailing Months -8,855,986
Net Income Past Year -10,892,511
Net Income Prior Year -6,654,940
Quarterly Revenue Growth YOY 314.30%
5-Year Revenue Growth 23.85%

Balance Sheet

Total Cash Most Recent Quarter 1,055,544
Total Cash Past Year 90,135
Total Cash Prior Year 5,684,871
Net Cash Position Most Recent Quarter -1,369,230
Net Cash Position Past Year -565,153
Long Term Debt Past Year 655,288
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 2,424,774
Equity to Debt Ratio Past Year 0.00
Equity to Debt Ratio Most Recent Quarter 0.13
Total Stockholder Equity Past Year -977,612
Total Stockholder Equity Prior Year 7,310,680
Total Stockholder Equity Most Recent Quarter 372,799

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.01
MACD Signal 0.01
20-Day Bollinger Lower Band 0.60
20-Day Bollinger Middle Band 1.24
20-Day Bollinger Upper Band 1.88
Beta 1.46
RSI 56.54
50-Day SMA 2.67
200-Day SMA 46.78

System

Modified 3/26/2024 10:48:13 PM EST